267 related articles for article (PubMed ID: 14597244)
1. Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.
Meglic L; Stegnar M; Milanez T; Bozic M; Peterlin B; Peternel P; Novak-Antolic Z
Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):157-63. PubMed ID: 14597244
[TBL] [Abstract][Full Text] [Related]
2. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
Jusić A; Balić D; Avdić A; Pođanin M; Balić A
Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
5. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
6. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
[TBL] [Abstract][Full Text] [Related]
8. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
[TBL] [Abstract][Full Text] [Related]
9. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
10. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
12. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
[TBL] [Abstract][Full Text] [Related]
14. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F
Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637
[TBL] [Abstract][Full Text] [Related]
15. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
[TBL] [Abstract][Full Text] [Related]
16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
17. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
[TBL] [Abstract][Full Text] [Related]
18. The role of point mutations in the genes, predisposing inherited thrombophilia in the pathogeneses of proximal and distal deep vein thrombosis in Georgian population.
Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
Georgian Med News; 2014 Feb; (227):98-102. PubMed ID: 24632657
[TBL] [Abstract][Full Text] [Related]
19. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
[TBL] [Abstract][Full Text] [Related]
20. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
